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Abstract
Background: Individuals with dyslipidemia often develop type 2 diabetes, and diabetic patients often have
dyslipidemia. It remains to be determined whether there are genetic connections between the 2 disorders.
Methods: A female F2 cohort, generated from BALB/cJ (BALB) and SM/J (SM) Apoe-deficient (Apoe
−/−) strains, was
started on a Western diet at 6 weeks of age and maintained on the diet for 12 weeks. Fasting plasma glucose and
lipid levels were measured before and after 12 weeks of Western diet. 144 genetic markers across the entire
genome were used for quantitative trait locus (QTL) analysis.
Results: One significant QTL on chromosome 9, named Bglu17 [26.4 cM, logarithm of odds ratio (LOD): 5.4], and 3
suggestive QTLs were identified for fasting glucose levels. The suggestive QTL near the proximal end of
chromosome 9 (2.4 cM, LOD: 3.12) was replicated at both time points and named Bglu16. Bglu17 coincided with a
significant QTL for HDL (high-density lipoprotein) and a suggestive QTL for non-HDL cholesterol levels. Plasma
glucose levels were inversely correlated with HDL but positively correlated with non-HDL cholesterol levels in F2
mice on either chow or Western diet. A significant correlation between fasting glucose and triglyceride levels was
also observed on the Western diet. Haplotype analysis revealed that “lipid genes” Sik3, Apoa1, and Apoc3 were
probable candidates for Bglu17.
Conclusions: We have identified multiple QTLs for fasting glucose and lipid levels. The colocalization of QTLs for
both phenotypes and the sharing of potential candidate genes demonstrate genetic connections between
dyslipidemia and type 2 diabetes.
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Background
Individuals with dyslipidemia have an increased risk of
developing type 2 diabetes (T2D), and diabetic patients
often have dyslipidemia, which includes elevations in
plasma triglyceride and low-density lipoprotein (LDL)
cholesterol levels and reductions in high-density lipopro-
tein (HDL) cholesterol levels [1]. Part of the increased
diabetic risk associated with dyslipidemia is due to gen-
etic variations that influence both lipoprotein homeosta-
sis and the development of T2D. Indeed, a few rare gene
mutations result in both dyslipidemia and T2D, which
include ABCA1 [2], LIPE [3], LPL [4], and LRP6 [5].
Genome-wide association studies (GWAS) have iden-
tified >150 loci associated to variation in plasma lipids
[6, 7] and >70 loci associated with T2D, fasting plasma
glucose, glycated hemoglobin (HbA1c), or insulin resistance
[8–10]. Nearly a dozen of the loci detected are associated
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with both lipid and T2D-related traits at the genome-wide
significance level, including GCKR, FADS1, IRS1, KLF14,
and HFE (http://www.genome.gov/GWAStudies/). Surpris-
ingly, half of them have shown opposite allelic effect on
dyslipidemia and glucose levels [11], and this is in contrary
to the positive correlations observed at the clinical level.
Furthermore, it is challenging to establish causality between
genetic variants and complex traits in humans due to small
gene effects, complex genetic structure, and environmental
influences.
A complementary approach to finding genetic compo-
nents in human disease is to use animal models. Apoli-
poprotein E-deficient (Apoe−/−) mice are a commonly
used mouse model of dyslipidemia, with elevations in
non-HDL cholesterol levels and reductions in HDL
levels, even when fed a low fat chow diet [12, 13]. High
fat diet feeding aggravates dyslipidemia. Moreover, these
mice develop all phases of atherosclerotic lesions seen in
humans [14] and are extensively used for atherosclerosis
research [15–18]. We have found that Apoe−/− mice with
certain genetic backgrounds develop significant hyper-
glycemia and T2D when fed a Western-type diet but be-
come resistant with some other genetic backgrounds
[16, 19, 20]. BALB/cJ (BALB) and SM/J (SM) Apoe−/−
mice exhibit differences in dyslipidemia and T2D-related
phenotypes [16]. The objective of the present study was
to explore potential genetic connections between dyslip-
idemia and T2D through quantitative trait locus (QTL)
analysis of a female cohort derived from an intercross
between BALB-Apoe−/− and SM-Apoe−/− mice.
Methods
Ethics statement
All procedures were in accordance with current National
Institutes of Health guidelines (https://grants.nih.gov/
grants/olaw/Guide-for-the-Care-and-use-of-laboratory-
animals.pdf ) and approved by the institutional Animal
Care and Use Committee (protocol #: 3109). Blood was
drawn from the retro-orbital plexus of overnight fasted
mice with the animals under isoflurane anesthesia.
Animals, experimental design and procedures
BALB and SM Apoe−/− mice were created using the clas-
sic congenic breeding strategy, as described [16]. BALB-
Apoe−/− mice were crossed with SM-Apoe−/− mice to
generate F1s, which were intercrossed by brother-sister
mating to generate a female F2 cohort. Mice were
weaned at 3 weeks of age onto a rodent chow diet. At
6 weeks of age, female F2 mice were started on a Western
diet containing 21 % fat, 34.1 % sucrose, 0.15 % choles-
terol, and 19.5 % casein by weight (Harlan Laboratories,
TD 88137) and maintained on the diet for 12 weeks. Mice
were bled twice: once before initiation of the Western diet
and once at the end of the 12-week feeding period.
Overnight fasted mice were bled into tubes containing
8 μL of 0.5 mol/L ethylenediaminetetraacetic acid. Plasma
was prepared and stored at −80 °C before use.
Housing and husbandry
Breeding pairs were housed in a cage of 1 adult male
and 2 females, and litters were weaned at 3 weeks of age
onto a rodent chow diet in a cage of 5 or less. At 6 weeks
of age, F2 mice were switched onto the Western diet and
maintained on the diet for 12 weeks. All mice were housed
under a 12-h light/dark cycle at an ambient temperature
of 23 °C and allowed free access to water and drinking
food. Mice were fasted overnight before blood samples
were collected.
Measurements of plasma glucose and lipid levels
Plasma glucose was measured with a Sigma glucose
(HK) assay kit, as reported with modification to a longer
incubation time [21]. Briefly, 6 μl of plasma samples
were incubated with 150 μl of assay reagent in a 96-well
plate for 30 min at 30 °C. The absorbance at 340 nm
was read on a Molecular Devices (Menlo Park, CA) plate
reader. The measurements of total cholesterol, HDL
cholesterol, and triglyceride were performed as reported
previously [13]. Non-HDL cholesterol was calculated as
the difference between total and HDL cholesterol.
Genotyping
Genomic DNA was isolated from the tails of mice by
using the phenol/chloroform extraction and ethanol pre-
cipitation method. The Illumina LD linkage panel consist-
ing of 377 SNP loci was used to genotype the F2 cohort.
Microsatellite markers were typed for chromosome 8
where SNP markers were uninformative in distinguishing
the parental origin of alleles. DNA samples from the two
parental strains and their F1s served as controls. Unin-
formative SNPs were excluded from QTL analysis. SNP
markers were also filtered based on the expected pattern
in the control samples, and F2 mice were filtered based on
95 % call rates in genotype calls. After filtration, 228 F2s
and 144 markers were included in genome-wide QTL
analysis.
Statistical analysis
QTL analysis was performed using J/qtl and Map Man-
ager QTX software as previously reported [19, 22, 23].
One thousand permutations of trait values were run to
define the genome-wide LOD (logarithm of odds) score
threshold needed for significant or suggestive linkage of
each trait. Loci that exceeded the 95th percentile of
the permutation distribution were defined as significant
(P < 0.05) and those exceeding the 37th percentile were
suggestive (P < 0.63).
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Prioritization of positional candidate genes
The Sanger SNP database (http://www.sanger.ac.uk/
sanger/Mouse_SnpViewer/rel-1410) was used to prioritize
candidate genes for overlapping QTLs affecting plasma
glucose and HDL cholesterol levels on chromosome (Chr)
9, which were mapped in two or more crosses derived
from different parental strains for either phenotype. We
converted the original mapping positions in cM for the
confidence interval to physical positions in Mb and then
examined SNPs within the confidence interval. Probable
candidate genes were defined as those with one or more
SNPs in coding or upstream promoter regions that were
shared by the parental strains carrying the “high” allele
but were different from the parental strains carrying the
“low” allele at a QTL, as previously reported [24].
Results
Trait value distributions
Fasting plasma glucose and lipid levels of F2 mice were
measured before and after 12-weeks of Western diet.
Values of fasting plasma glucose, non-HDL cholesterol
and triglyceride levels of F2 mice on both chow and
Western diets and of HDL cholesterol level on the
chow diet were normally or approximately normally
Fig. 1 The distributions of trait values for fasting plasma glucose, HDL, non-HDL cholesterol and triglyceride of 228 female F2 mice derived from
an intercross between BALB-Apoe−/− and SM-Apoe−/− mice. Fasting blood was collected once before initiation of the Western diet (left panel) and
once after 12 weeks on the Western diet (right panel). Graphs were created using a plotting function of J/qtl software
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distributed (Fig. 1). Values of square root-transformed
HDL cholesterol levels on the Western diet showed a
normal distribution. These data were then analyzed to
search for QTLs affecting the traits. Loci with a genome-
wide suggestive or significant P value are presented in
Table 1.
Fasting glucose levels
A genome-wide scan for main effect QTL revealed a
suggestive QTL near the proximal end of Chr9 for fast-
ing glucose when mice were fed the chow diet (2.37 cM,
LOD: 2.21) (Fig. 2 and Table 1). As this QTL was repli-
cated on the Western diet, it was named Bglu16. For
fasting glucose levels on the Western diet, a significant
QTL on Chr9 and 3 suggestive QTLs, including Bglu16
on Chr9, were identified. The significant QTL on Chr9
peaked at 26.37 cM and had a LOD score of 5.425. It
was named Bglu17. The suggestive QTL near the middle
portion of Chr5 (67.4 cM, LOD 2.18) replicated Bglu13,
initially mapped in a B6 x BALB Apoe−/− intercross [21].
The suggestive QTL on distal Chr5 (101.24 cM, LOD
3.198) was novel. The BALB allele conferred an in-
creased glucose level for both of the Chr9 QTLs while
the SM allele conferred increased glucose levels for the
2 Chr5 QTLs (Table 2).
Fasting lipid levels
Genome-wide scans for main effect QTLs showed that
HDL, non-HDL cholesterol, and triglyceride levels were
each controlled by multiple QTLs (Figs. 3, 4 and 5;
Table 1). For HDL, 3 significant QTLs, located on Chr1,
Chr7 and Chr9, and 1 suggestive QTL on Chr10, were
Table 1 Significant and suggestive QTLs for plasma glucose and lipid levels in female F2 mice derived from BALB-Apoe
−/− and SM-
Apoe−/− mice
Locus Chr Trait LODa p-valueb Peak (cM) 95 % CIc High allele Mode of inheritenced
Bglu16 9 Glucose-C 2.214 0.549 2.37 0.37–30.37 B Additive
Bglu13 5 Glucose-W 2.1.8 <0.63 67.4 45.4–80.03 S Recessive
- 5 Glucose-W 3.198 0.097 101.24 29.40–101.24 S Additive
Bglu16 9 Glucose-W 3.12 <0.63 2.37 0–10.37 B Additive
Bglu17 9 Glucose-W 5.425 0.001 26.37 16.37–40.37 B Additive
Hdlq5 1 HDL-C 8.64 0.000 93.52 87.52–97.02 S Additive
Hdlcl1 7 HDL-C 2.668 0.321 61.33 35.57–89.57 S Dominant
Hdlq17 9 HDL-C 4.614 0.014 30.37 16.37–32.37 S Additive
Hdlq26 10 HDL-C 2.181 0.591 61.22 25.03–61.22 S Dominant
Hdlq5 1 HDL-W 13.944 0.000 87.52 83.52–93.52 S Additive
Hdlcl1 7 HDL-W 3.658 0.034 85.57 77.57–89.67 S Additive
Hdlq17 9 HDL-W 10.625 0.000 30.42 24.37–30.53 S Additive
Chol7 1 non-HDL-C 2.093 0.626 66.95 9.52–74.56 B Recessive
Nhdlq15 2 non-HDL-C 2.56 0.321 23.86 8.73–38.73 B Additive
Hdlq34 5 non-HDL-C 2.106 0.614 19.4 19.4–30.5 S Additive
Pnhdlc1 6 non-HDL-C 2.489 0.362 57.53 1.53–77.53 B Recessive
Nhdlq1 8 non-HDL-C 2.221 0.537 44.14 10.14–60.14 B Additive
Nhdlq12 12 non-HDL-C 2.73 0.245 39.41 15.41–59.41 B Additive
Nhdlq15 2 non-HDL-W 4.79 0.002 31.80 22.73–40.73 B Dominant
Nhdlq11 9 non-HDL-W 2.136 0.585 32.37 0.37–75.33 B Additive
- 11 non-HDL-W 2.332 0.436 1.99 1.99–17.99 B Dominant
Nhdlq16 16 non-HDL-W 3.99 0.011 46.66 35.43–46.66 S Dominant
Tgq11 2 Triglyceride-C 2.952 0.169 26.73 12.73–60.83 B Additive
- 5 Triglyceride-C 2.759 0.234 80.03 73.40–93.40 S Heterosis
Trglyd 1 Triglyceride-W 3.291 0.091 97.02 79.24–97.02 S Additive
aLOD scores were obtained from genome-wide QTL analysis using J/qtl software. The significant LOD scores were highlighted in bold. The suggestive and significant
LOD score thresholds were determined by 1,000 permutation tests for each trait. Suggestive and significant LOD scores were 2.116 and 3.429, respectively, for glucose
on the chow diet; 2.056 and 3.569 for glucose on the Western diet; 2.127 and 3.725 for HDL cholesterol, 2.09 and 3.662 for non-HDL cholesterol, and 2.102 and 3.522 for
triglyceride on the chow diet; 2.10 and 3.486 for HDL, 2.123 and 3.628 for non-HDL, and 2.123 and 3.628 for triglyceride on the Western diet
bThe p-values reported represent the level of genome-wide significance
c95 % Confidence interval in cM defined by a whole genome QTL scan
dMode of inheritance was defined according to allelic effect at the nearest marker of a QTL
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identified. All 3 significant QTLs for HDL were detected
when mice were fed either chow or Western diet, while
the suggestive QTL on Chr10 was found when mice
were on the chow diet. The significant QTL on Chr1
replicated Hdlq5, which had been mapped in numerous
crosses [25]. The Chr7 QTL replicated Hdlcl1, initially
mapped in (PERA/EiJ x B6-Ldlr)) x B6-Ldlr backcross
[26]. The Chr9 QTL replicated Hdlq17, previously
mapped in B6 x 129S1/SvImJ F2 mice [27]. The suggest-
ive QTL on Chr10 overlapped with Hdlq26 mapped in a
SM/J x NZB/BlNJ intercross [28]. For all 4 HDL QTLs,
F2 mice homozygous for the SS allele had higher HDL
levels than those homozygous for the BB allele (Table 2).
For non-HDL cholesterol levels, 6 suggestive QTLs
were detected when F2 mice were fed the chow diet, and
2 significant and 2 suggestive QTLs were detected on
the Western diet (Fig. 4). The 2 significant QTLs on
Chr2 and Chr16 and the suggestive QTL on Chr11 were
novel. The former 2 QTLs were named Nhdlq15 and
Nhdlq16, respectively. Nhdlq15 peaked at 31.8 cM on
Chr2 and affected non-HDL levels in a dominant mode
from the BB allele while Nhdlq16 peaked at 46.66 cM on
Chr16 and affected non-HDL levels in a dominant mode
from the SS allele. The rest replicated previously identi-
fied ones in other mouse crosses: The Chr1 QTL peaked
at 66.95 cM, overlapping with Chol7 mapped in an inter-
cross of 129S1/SvImJ and CAST/Ei mice [29]. The Chr5
QTL overlapped with Hdlq34 mapped in PERA/EiJ × I/
LnJ and PERA/EiJ × DBA/2 J intercrosses [30]. The Chr6
QTL overlapped with Pnhdlc1, initially mapped in a B6 x
CASA/Rk intercross and then replicated in B6 x C3H
Apoe−/− F2 mice [31, 32]. The Chr8 QTL replicated
Nhdlq1, initially mapped in B6 x 129S1/SvImJ F2 mice
[33]. The Chr9 QTL replicated Nhdlq11, initially mapped
Fig. 2 Genome-wide scans to search for main effect loci influencing fasting plasma glucose levels of female F2 mice when fed a chow (a) or
Western diet (b). Chromosomes 1 through X are represented numerically on the X-axis. The Y-axis represents the LOD score. Two horizontal
dashed lines denote genome-wide empirical thresholds for suggestive (P = 0.63) and significant (P = 0.05) linkage
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Table 2 Allelic effects in different QTLs on plasma glucose and lipids of female F2 mice derived from BALB and SM Apoe
−/− mice
Locus name Chr Trait LOD Peak (cM) Closest marker BB SS SB
Bglu16 9 Glucose-C 2.214 2.37 rs13480073 109.0 ± 28.7 (n = 44) 93.9 ± 22.9 (n = 43) 97.4 ± 22.6 (n = 141)
Bglu13 5 Glucose-W 2.1.8 67.4 rs3726547 144.4 ± 30.6 (n = 43) 153.5 ± 40.4 (n = 88) 142.9 ± 35.3 (n = 97)
- 5 Glucose-W 3.198 101.24 rs13478578 132.7 ± 31.3 (n = 51) 158.8 ± 41.8 (n = 63) 147.5 ± 34.0 (n = 113)
Bglu16 9 Glucose-W 3.12 2.37 rs13480073 165.3 ± 40.9 (n = 54) 138.3 ± 30.0 (n = 43) 144.4 ± 35.7 (n = 141)
Bglu17 9 Glucose-W 5.425 26.37 CEL.9_49183636 168.0 ± 39.8 (n = 42) 134.7 ± 26.5 (n = 62) 146.1 ± 37.1 (n = 124)
Hdlq5 1 HDL-C 8.64 93.52 rs13476259 49.5 ± 20.9 (n = 60) 73.2 ± 26.5 (n = 62) 55.1 ± 19.4 (n = 106)
Hdlcl1 7 HDL-C 2.668 61.33 rs3724711 49.0 ± 20.0 (n = 50) 58.3 ± 21.0 (n = 63) 62.9 ± 25.5 (n = 115)
Hdlq17 9 HDL-C 4.614 30.37 CEL.9_49183636 49.5 ± 15.9 (n = 42) 69.4 ± 26.8 (n = 62) 56.2 ± 22.5 (n = 124)
Hdlq26 10 HDL-C 2.181 61.22 rs3688351 50.7 ± 19.2 (n = 60) 59.4 ± 21.9 (n = 53) 62.4 ± 25.8 (n = 114)
Hdlq5 1 sqrtHDL-W 13.944 87.52 rs3685643 66.6 ± 50.2 (n = 57) 201.1 ± 118.8 (n = 62) 117.0 ± 97.1 (n = 109)
Hdlcl1 7 sqrtHDL-W 3.658 85.57 rs6216320 95.5 ± 87.6 (n = 63) 173.3 ± 126.7 (n = 55) 122.4 ± 98.4 (n = 110)
Hdlq17 9 sqrtHDL-W 10.625 30.42 CEL.9_49183636 57.6 ± 49.3 (n = 42) 183.3 ± 115.0 (n = 62) 122.8 ± 101.7 (n = 124)
Chol7 1 non-HDL-C 2.093 66.95 rs6354736 279.5 ± 62.8 (n = 56) 257.8 ± 56.9 (n = 57) 251.2 ± 52.1 (n = 114)
Nhdlq15 2 non-HDL-C 2.56 23.86 mCV23209429 273.9 ± 56.1 (n = 55) 238.0 ± 47.0 (n = 53) 262.7 ± 59.0 (n = 120)
Hdlq34 5 non-HDL-C 2.106 19.4 rs3658401 244.5 ± 54.7 (n = 63) 276.0 ± 53.2 (n = 61) 259.3 ± 58.3 (n = 104)
Pnhdlc1 6 non-HDL-C 2.489 57.53 rs13478909 279.6 ± 51.3 (n = 51) 252.0 ± 65.2 (n = 57) 254.8 ± 53.5 (n = 120)
Nhdlq1 8 non-HDL-C 2.221 44.14 D8Mit50 275.0 ± 54.5 (n = 60) 242.4 ± 57.4 (n = 57) 262.9 ± 55.6 (n = 96)
Nhdlq12 12 non-HDL-C 2.73 39.41 rs6195664 278.6 ± 52.3 (n = 62) 243.8 ± 57.8 (n = 59) 257.4 ± 56.5 (n = 107)
Nhdlq15 2 non-HDL-W 4.79 31.8 rs13476507 954.1 ± 156.0 (n = 56) 806.9 ± 158.2 (n = 47) 915.6 ± 166.1 (n = 125)
Nhdlq11 9 non-HDL-W 2.136 32.37 rs3709825 958.4 ± 211.4 (n = 42) 856.8 ± 165.3 (n = 62) 906.6 ± 149.5 (n = 124)
- 11 non-HDL-W 2.332 1.99 rs4222040 927.3 ± 149.8 (n = 67) 849.0 ± 165.1 (n = 69) 917.0 ± 170.5 (n = 85)
Nhdlq16 16 non-HDL-W 3.99 46.66 rs3721202 820.2 ± 152.7 (n = 56) 931.9 ± 146.4 (n = 52) 928.4 ± 174.6 (n = 120)
Tgq11 2 Triglyceride-C 2.952 26.73 mCV23209429 123.7 ± 35.7 (n = 55) 101.9 ± 34.6 (n = 53) 107.3 ± 31.8 (n = 120)
- 5 Triglyceride-C 2.759 80.03 gnf05.120.578 110.2 ± 33.2 (n = 43) 119.3 ± 35.8 (n = 88) 101.6 ± 31.3 (n = 97)
Trglyd 1 Triglyceride-W 3.291 97.02 rs13476259 94.0 ± 28.6 (n = 59) 115.3 ± 33.0 (n = 62) 100.7 ± 30.8 (n = 106)
Bglu16 9 Glucose-C 2.214 2.37 rs13480073 109.0 ± 28.7 (n = 44) 93.9 ± 22.9 (n = 43) 97.4 ± 22.6 (n = 141)
Bglu13 5 Glucose-W 2.1.8 67.4 rs3726547 144.4 ± 30.6 (n = 43) 153.5 ± 40.4 (n = 88) 142.9 ± 35.3 (n = 97)
- 5 Glucose-W 3.198 101.24 rs13478578 132.7 ± 31.3 (n = 51) 158.8 ± 41.8 (n = 63) 147.5 ± 34.0 (n = 113)
Bglu16 9 Glucose-W 3.12 2.37 rs13480073 165.3 ± 40.9 (n = 54) 138.3 ± 30.0 (n = 43) 144.4 ± 35.7 (n = 141)
Bglu17 9 Glucose-W 5.425 26.37 CEL.9_49183636 168.0 ± 39.8 (n = 42) 134.7 ± 26.5 (n = 62) 146.1 ± 37.1 (n = 124)
Hdlq5 1 HDL-C 8.64 93.52 rs13476259 49.5 ± 20.9 (n = 60) 73.2 ± 26.5 (n = 62) 55.1 ± 19.4 (n = 106)
Hdlcl1 7 HDL-C 2.668 61.33 rs3724711 49.0 ± 20.0 (n = 50) 58.3 ± 21.0 (n = 63) 62.9 ± 25.5 (n = 115)
Hdlq17 9 HDL-C 4.614 30.37 CEL.9_49183636 49.5 ± 15.9 (n = 42) 69.4 ± 26.8 (n = 62) 56.2 ± 22.5 (n = 124)
Hdlq26 10 HDL-C 2.181 61.22 rs3688351 50.7 ± 19.2 (n = 60) 59.4 ± 21.9 (n = 53) 62.4 ± 25.8 (n = 114)
Hdlq5 1 sqrtHDL-W 13.944 87.52 r[55]s3685643 66.6 ± 50.2 (n = 57) 201.1 ± 118.8 (n = 62) 117.0 ± 97.1 (n = 109)
Hdlcl1 7 sqrtHDL-W 3.658 85.57 rs6216320 95.5 ± 87.6 (n = 63) 173.3 ± 126.7 (n = 55) 122.4 ± 98.4 (n = 110)
Hdlq17 9 sqrtHDL-W 10.625 30.42 CEL.9_49183636 57.6 ± 49.3 (n = 42) 183.3 ± 115.0 (n = 62) 122.8 ± 101.7 (n = 124)
Chol7 1 non-HDL-C 2.093 66.95 rs6354736 279.5 ± 62.8 (n = 56) 257.8 ± 56.9 (n = 57) 251.2 ± 52.1 (n = 114)
Nhdlq15 2 non-HDL-C 2.56 23.86 mCV23209429 273.9 ± 56.1 (n = 55) 238.0 ± 47.0 (n = 53) 262.7 ± 59.0 (n = 120)
Hdlq34 5 non-HDL-C 2.106 19.4 rs3658401 244.5 ± 54.7 (n = 63) 276.0 ± 53.2 (n = 61) 259.3 ± 58.3 (n = 104)
Pnhdlc1 6 non-HDL-C 2.489 57.53 rs13478909 279.6 ± 51.3 (n = 51) 252.0 ± 65.2 (n = 57) 254.8 ± 53.5 (n = 120)
Nhdlq1 8 non-HDL-C 2.221 44.14 D8Mit50 275.0 ± 54.5 (n = 60) 242.4 ± 57.4 (n = 57) 262.9 ± 55.6 (n = 96)
Nhdlq12 12 non-HDL-C 2.73 39.41 rs6195664 278.6 ± 52.3 (n = 62) 243.8 ± 57.8 (n = 59) 257.4 ± 56.5 (n = 107)
Nhdlq15 2 non-HDL-W 4.79 31.8 rs13476507 954.1 ± 156.0 (n = 56) 806.9 ± 158.2 (n = 47) 915.6 ± 166.1 (n = 125)
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in B6 x C3H Apoe−/− F2 mice [32]. The Chr12 QTL
peaked at 44.14 cM, overlapping with Nhdlq12 mapped in
a B6 x C3H Apoe−/− F2 intercross [32].
For triglyceride levels, 3 suggestive QTLs, located on
Chr1, 2, and 5, respectively, were identified (Fig. 5). The
Chr1 QTL peaked at 97 cM, 17 cM distal the Apoa2
gene (80 cM). The Chr2 QTL replicated Tgq11, mapped
in an intercross between DBA/1J and DBA/2J [34]. The
Chr5 QTL was novel.
Coincident QTLs for fasting glucose and lipids
LOD score plots for Chr9 showed that the QTL for fast-
ing glucose (Bglu17) coincided precisely with the QTLs
for HDL (Hdlq17) and non-HDL (Nhdlq11) in the
Table 2 Allelic effects in different QTLs on plasma glucose and lipids of female F2 mice derived from BALB and SM Apoe
−/− mice
(Continued)
Nhdlq11 9 non-HDL-W 2.136 32.37 rs3709825 958.4 ± 211.4 (n = 42) 856.8 ± 165.3 (n = 62) 906.6 ± 149.5 (n = 124)
- 11 non-HDL-W 2.332 1.99 rs4222040 927.3 ± 149.8 (n = 67) 849.0 ± 165.1 (n = 69) 917.0 ± 170.5 (n = 85)
Nhdlq16 16 non-HDL-W 3.99 46.66 rs3721202 820.2 ± 152.7 (n = 56) 931.9 ± 146.4 (n = 52) 928.4 ± 174.6 (n = 120)
Tgq11 2 Triglyceride-C 2.952 26.73 mCV23209429 123.7 ± 35.7 (n = 55) 101.9 ± 34.6 (n = 53) 107.3 ± 31.8 (n = 120)
- 5 Triglyceride-C 2.759 80.03 gnf05.120.578 110.2 ± 33.2 (n = 43) 119.3 ± 35.8 (n = 88) 101.6 ± 31.3 (n = 97)
Trglyd 1 Triglyceride-W 3.291 97.02 rs13476259 94.0 ± 28.6 (n = 59) 115.3 ± 33.0 (n = 62) 100.7 ± 30.8 (n = 106)
Chr chromosome, LOD logarithm of odds, C chow diet, W Western diet, BB homozygous BALB allele, SS homozygous SM allele, SM heterozygous allele
Data are mean ± SD. The units for these measurements are mg/dL for plasma glucose or lipid levels. The number in the brackets represents the number of
progeny with a specific genotype at a peak marker. The significant QTLs and their LOD scores were highlighted in bold
Fig. 3 Genome-wide scans to search for loci influencing HDL cholesterol levels of female F2 mice when fed a chow (a) or Western diet (b). Three
significant loci on chromosomes 1, 7, and 9 and one suggestive locus on chromosome 10 were detected to affect HDL cholesterol levels of mice
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confidence interval (Fig. 6). F2 mice homozygous for the
BB allele exhibited elevated levels of fasting glucose and
non-HDL but decreased levels of HDL, compared to
those homozygous for the SS allele (Table 2). These
QTLs affected their respective trait values in an additive
manner.
Correlations between plasma glucose and lipid levels
The correlations of fasting glucose levels with plasma
levels of HDL, non-HDL cholesterol, or triglyceride were
analyzed with the F2 population (Fig. 7). A significant in-
verse correlation between fasting glucose and HDL chol-
esterol levels was observed when the mice were fed a
chow (R = −0.220; P = 8.1E-4) or Western diet (R = −0.257;
P = 8.5E-5). F2 mice with higher HDL cholesterol levels
had lower fasting glucose levels. Conversely, significant
positive correlations between fasting glucose and non-
HDL cholesterol levels were observed when mice were fed
either chow (R = 0.194; P = 3.31E-3) or Western diet (R =
0.558; P = 4.7E-20). F2 mice with higher non-HDL choles-
terol levels also had higher fasting glucose levels, especially
on the Western diet. A significant positive correlation be-
tween plasma levels of fasting glucose and triglyceride was
observed when mice were fed the Western diet (R = 0.377;
P = 3.9E-9) but not the chow diet (R = 0.065; P = 0.330).
Prioritization of positional candidate genes for Chr9
coincident QTLs
Bglu17 on Chr9 has been mapped in 3 separate inter-
crosses, including previously reported C57BLKS x DBA/
2 [35] and B6-Apoe−/− x BALB-Apoe−/− crosses [21].
Hdlq17 on Chr9 has been mapped in multiple crosses,
including B6 x 129, B6 x CAST/EiJ, B6-Apoe−/− x
C3H-Apoe−/−, and B6-Apoe−/− x BALB-Apoe−/− crosses
Fig. 4 Genome-wide scans to search for loci influencing non-HDL cholesterol levels of female F2 mice fed a chow (a) or Western diet (b). Two
significant loci on chromosomes 2 and 16 were identified to affect non-HDL cholesterol levels of mice fed the Western diet
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[24, 27, 31, 32, 36–38]. We conducted haplotype analyses
using Sanger SNP database to prioritize positional candi-
date genes for both QTLs. Prioritized candidate genes for
Hdlq17 are shown in Additional file 1: Table S1, and can-
didate genes for Bglu17 are shown in Additional file 2:
Table S2. Most candidates for Hdlq17 are also candidate
genes for Bglu17. These candidates contain one or more
non-synonymous SNPs in the coding regions or SNPs in
the upstream regulatory region that are shared by the high
allele strains but are different from the low allele strains at
the QTL. All candidate genes were further examined for
associations with relevant human diseases using the NIH
GWAS database (http://www.genome.gov/GWAStudies/).
Sik3, Apoa1, and Apoc3 have been shown to be associated
with variations in total, HDL, LDL-cholesterol or tri-
glyceride levels [6, 7, 39], and Cadm1 with obesity-related
traits [40].
Discussion
BALB and SM are two mouse strains that exhibit dis-
tinct differences in HDL, non-HDL cholesterol, and type
2 diabetes-related traits when deficient in Apoe [16].
BALB-Apoe−/− mice have higher HDL, lower non-HDL
cholesterol, and lower glucose levels than SM-Apoe−/−
mice when they are fed a Western diet. To identify the
genetic factors responsible for these differences, we per-
formed QTL analysis on a female cohort derived from
an intercross between the two Apoe−/− strains. We have
identified four loci contributing to fasting glucose levels,
four loci contributing to HDL cholesterol levels, nine
loci for non-HDL cholesterol levels, and three loci for
triglyceride levels. Moreover, we have observed genetic
connections between dyslipidemia and type 2 diabetes in
that the QTL for fasting glucose is colocalized with the
QTLs for HDL and non-HDL cholesterol on chromosome
Fig. 5 Genome-wide scans to search for loci influencing triglyceride levels of female F2 mice fed a chow (a) or Western diet (b). Three suggestive
loci were identified for triglyceride levels
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9 and these coincident QTLs share a large fraction of
potential candidate genes.
We identified a significant QTL on chromosome 9,
peaked at 26 cM, which affected fasting plasma glucose
levels when mice were fed a chow or Western diet. We
named it Bglu17 to represent a novel locus regulating
fasting glucose levels in the mouse. This locus is over-
lapping with a significant QTL (not named) for blood
glucose levels on the intraperitoneal glucose tolerance
test identified in a BKS-Cg-Leprdb+/+m x DBA/2 inter-
cross and a suggested QTL identified in a B6-Apoe−/− x
BALB-Apoe−/− intercross [21, 35]. Interestingly, we
found that Bglu17 coincided precisely with Hdlq17, a
QTL for HDL cholesterol levels, and Nhdlq11, a QTL
for non-HDL cholesterol levels. The colocalization of
two or more QTLs for different traits suggests that these
traits are controlled either by the same gene(s) or closely
linked but different individual genes. Hdlq17 has been
mapped in multiple crosses derived from inbred mouse
strains whose genomes have been resequenced by Sanger,
including B6, 129, BALB, C3H/HeJ, and CAST/EiJ
[24, 27, 31, 32, 36–38]. Nhdlq11 was previously
mapped in a NZB/BINJ x SM/JF2 cross and a B6-
Apoe−/− x C3H-Apoe−/− intercross [32, 41]. To deter-
mine whether Bglu17 and Hdlq17 share the same
underlying candidate genes, we performed haplotype
analyses on those crosses that led to the identification
of the QTLs. The number of shared genetic variants
between Bglu17 and Hdlq17 was surprisingly high. Of
them, Sik3, Apoa1, and Apoc3 are located precisely
underneath the linkage peak of Bglu17 and Hdlq17,
and they are also functional candidate genes of
Hdlq17. Indeed, recent GWAS studies have associated
these three genes with dyslipidemia or variations in
HDL, LDL cholesterol, and triglyceride levels [6, 39, 42].
The finding in this study strongly suggests that one
or more of these “lipid genes” might be the causal
gene(s) of Bglu17, contributing to variation in fasting
glucose levels. Although it is unknown how they affect
glucose homeostasis, one probable effect path is through
the influence on plasma lipid levels, which then pre-
dispose variation in glucose-related traits. The current
Fig. 6 LOD score plots for fasting glucose, HDL, and non-HDL cholesterol of F2 mice fed the Western diet on chromosome 9. Plots were created
with the interval mapping function of Map Manager QTX. The histogram in the plot estimates the confidence interval for a QTL. Two green
vertical lines represent genome-wide significance thresholds for suggestive or significant linkage (P = 0.63 and P = 0.05, respectively). Black plots
reflect the LOD score calculated at 1-cM intervals, the red plot represents the effect of the BALB allele, and the blue plot represents the effect of
the SM allele. If BALB represents the high allele, then the red plot will be to the right of the graph; otherwise, it will be to the left
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observation on the significant correlations of fasting glu-
cose levels with HDL, non-HDL cholesterol, and triglycer-
ide levels in this cross supports this speculation. Plasma
lipid levels, especially non-HDL cholesterol, of the F2 mice
were significantly elevated on the Western diet, so were
the fasting glucose levels. When fed the Western diet,
Apoe−/− mice display a rapid rise in non-HDL cholesterol
levels, often reaching their peak within a couple of weeks
(unpublished data), whereas their blood glucose levels rise
more slowly and gradually within 12 weeks [43, 44]. This
difference in onset suggests a causal role for plasma lipids
in the rise of blood glucose in the Apoe−/− mouse model.
A significant reverse correlation was observed between
plasma HDL cholesterol levels and fasting glucose levels
in this cross on either chow or Western diet. This result
is consistent with the findings of prospective human
studies that low HDL levels can predict the future risk
of developing T2D and low HDL levels are more preva-
lent in diabetic patients than in the normal population
[45, 46]. HDL can increase insulin secretion from β-
cells, improve insulin sensitivity of the target tissues, and
accelerate glucose uptake by muscle via the AMP-
activated protein kinase [47]. A significant correlation of
non-HDL cholesterol levels with fasting glucose levels
was also observed in this cross, and the correlation was
extremely high when mice were fed the Western diet.
Emerging human studies have also revealed associations
of non-HDL cholesterol and ApoB with fasting glucose
levels and incident type 2 diabetes [48–50]. We previously
observed that the elevation of non-HDL cholesterol levels
in Apoe−/− mice during the consumption of a Western
diet induces a chronic, low-grade inflammation state char-
acterized by rises in circulating cytokines and infiltration
of monocytes/macrophages in various organs or tissues
[13, 17, 20, 43]. Inflammation in the islets impairs β-cell
function [20]. LDL can also directly affect function and
survival of β-cells [51]. In addition, high levels of LDL can
induce insulin resistance due to its lipotoxicity and effect
on endoplasmic reticulum stress [1].
Plasma triglyceride levels were strongly correlated with
fasting glucose levels in this cross on the Western diet,
although no significant correlation was found when mice
were fed the chow diet. Despite the strong correl-
ation, no overlapping QTLs were observed for fasting
glucose and triglyceride. The reason for the discrep-
ancy between non-HDL cholesterol and triglyceride in
terms of the presence or absence of colocalized QTLs
is unclear.
A suggestive QTL for fasting glucose near the prox-
imal end of chromosome 9 (2.37 cM) was detected in
Fig. 7 Correlations of fasting plasma glucose levels with plasma levels of HDL, non-HDL cholesterol and triglyceride in the F2 population fed a
chow (top row: a, b, c) or Western diet (bottom row: d, e, f). Each point represents values of an individual F2 mouse. The correlation coefficient (R) and
significance (P) are shown
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this cross, initially on the chow diet and then replicated
on the Western diet. The LOD score plot for chromosome
9 has shown 2 distinct peaks, one with a suggestive LOD
score at the proximal end and one with a significant LOD
score at a more distal region, suggesting the existence of
two loci for fasting glucose on the chromosome. The
bootstrap test, a statistical method for defining the con-
fidence interval of QTLs using simulation [52], also indi-
cated the existence of two QTLs for the trait on
chromosome 9. We named the proximal one Bglu16 to
represent a new QTL for fasting glucose in the mouse.
Naming a suggestive locus is considered appropriate if it
is repeatedly observed [53].
Two suggestive QTLs for fasting glucose on chromo-
some 5 were identified when mice were fed the Western
diet. The proximal one replicated Bglu13, recently
mapped in the B6-Apoe−/− x BALB-Apoe−/− cross [21].
One probable candidate gene for this QTL is Hnf1a,
which encodes hepatocyte nuclear factor 1α. In humans,
Hnf1a mutations are the most common cause of
maturity-onset diabetes of the young (MODY) [54]. The
suggestive QTL in the distal region was novel.
Most of the QTLs identified for plasma lipids confirm
those identified in previous studies, whereas two QTLs
for non-HDL are new and named Nhdlq15 and Nhdlq16,
respectively. The QTLs on distal chromosome 1 for
HDL and triglyceride has been mapped in a number of
mouse crosses, and Apoa2 has been identified as the
underlying causal gene [55]. However, the QTL (~90 cM)
mapped in this study showed that it was more distal to
the Apoa2 gene (80 cM), thus suggesting a different
underlying causal gene.
Conclusion
We have identified multiple QTLs contributing to dyslip-
idemia and hyperglycemia in a segregating F2 population.
The finding on the colocalization of QTLs for fasting glu-
cose, HDL and non-HDL cholesterol levels and the shar-
ing of probable candidate genes has demonstrated genetic
connections between dyslipidemia and type 2 diabetes.
The close correlations of fasting glucose with HDL, non-
HDL cholesterol, and triglyceride support the hypothesis
that dyslipidemia plays a causal role in the development of
type 2 diabetes [1]. The haplotype analysis has prioritized
candidates for either chromosome 9 QTL down to a
handful of genes. Nevertheless, functional studies need to
be performed to prove causality.
Availability of supporting data





Additional file 1: Table S1. Haplotype analysis to prioritize candidate
genes for HDL QTL Hdlq17 on chromosome 9. Sanger SNP database
(http://www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1410) was used to
prioritize candidate genes for this locus, which were mapped in 3
separate crosses derived from different inbred strains. A high allele strain
is the one that displays a larger allelic effect on HDL level at the locus
and a low allele strain is the one showing a smaller allelic effect on HDL
at the locus. (PDF 86 kb)
Additional file 2: Table S2. Haplotype for glucose QTL Bglu17 on
chromosome 9. Analysis was performed in the same way as for Hdlq17
illustrated above. (PDF 82 kb)
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